Supplementary Table S1 from Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies
Year: 2025
Type: supplementary-materials
Abstract: Supplementary Table 1. Clinical characteristics of patients with relapsed or refractory acute myeloid leukemia.
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4416627366